Stock research
EMBC Embecta Corp.
Healthcare • Drug Manufacturers - Specialty & Generic
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as...…
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
1Y change
-64.98%
Range high
$15.31
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in EMBC?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $3.68
- Day High
- $3.70
- Day Low
- $3.58
- 52w High
- $15.55
- 52w Low
- $2.77
- Volume
- 1,071,757
- Avg Volume
- Beta
- 0.807
* TTM/most recent where available
Company
- Ticker
- EMBC
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- US
- CEO
- Devdatt Kurdikar
- Employees
- 1850
- Website
- www.embecta.com
Key Metrics
- Market Cap
- 217M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).